Control of angiogenesis by heparin and other sulfated polysaccharides
- PMID: 1279952
- DOI: 10.1007/978-1-4899-2444-5_34
Control of angiogenesis by heparin and other sulfated polysaccharides
Abstract
Heparin and its related polysaccharides are revealed to have important new functions as regulators of blood vessel growth and regression. This regulatory activity may be explained in part by at least five mechanisms in which heparin and heparan sulfate interact with peptide growth factors: (1) Heparin and heparan sulfate have a high affinity for angiogenic growth factors such as the fibroblast growth factors and VEGF, as well as for angiogenic inhibitors such as thrombospondin and platelet factor 4. (2) Heparin and its related polysaccharides stabilize bFGF and other growth factors. (3) FGFs and thrombospondin are stored in the extracellular matrix bound to heparan sulfate; fragments of heparin or heparan sulfate may act as natural chaperones to shuttle bFGF or other growth factors to different cellular compartments. (5) Heparin-like low-affinity receptors on the surface of endothelial cells (and other cells), prepare FGFs for binding to their specific high affinity receptors; and (6) Heparin and its related polysaccharides potentiate angiostatic steroids. It is likely that future investigations will uncover even more fundamental regulatory roles for heparin as well as for other polysaccharides in the normal function of growth factors, especially in the complex process of angiogenesis.
Similar articles
-
Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.Semin Cancer Biol. 1992 Apr;3(2):81-7. Semin Cancer Biol. 1992. PMID: 1378313 Review.
-
Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.J Cell Physiol. 1995 Sep;164(3):482-90. doi: 10.1002/jcp.1041640306. J Cell Physiol. 1995. PMID: 7650058
-
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.Cytokine Growth Factor Rev. 2005 Apr;16(2):159-78. doi: 10.1016/j.cytogfr.2005.01.004. Epub 2005 Feb 2. Cytokine Growth Factor Rev. 2005. PMID: 15863032 Review.
-
Molecular and cellular mechanisms of angiogenesis.Important Adv Oncol. 1990:85-98. Important Adv Oncol. 1990. PMID: 1691138 Review. No abstract available.
-
Angiogenic and angiostatic factors in the molecular control of angiogenesis.Q J Nucl Med. 2003 Sep;47(3):149-61. Q J Nucl Med. 2003. PMID: 12897707 Review.
Cited by
-
2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis.Int J Exp Pathol. 2000 Jun;81(3):191-8. doi: 10.1046/j.1365-2613.2000.00150.x. Int J Exp Pathol. 2000. PMID: 10971740 Free PMC article.
-
Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.Mol Cell Biol. 1997 Apr;17(4):1938-46. doi: 10.1128/MCB.17.4.1938. Mol Cell Biol. 1997. PMID: 9121441 Free PMC article.
-
A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain.Oncotarget. 2016 Jan 12;7(2):1838-53. doi: 10.18632/oncotarget.6550. Oncotarget. 2016. PMID: 26673818 Free PMC article.
-
Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition.PLoS One. 2016 Dec 9;11(12):e0166655. doi: 10.1371/journal.pone.0166655. eCollection 2016. PLoS One. 2016. PMID: 27935954 Free PMC article.
-
Lymphangiogenesis: a new player in cancer progression.World J Gastroenterol. 2010 Aug 28;16(32):4003-12. doi: 10.3748/wjg.v16.i32.4003. World J Gastroenterol. 2010. PMID: 20731013 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical